pillbase.ru

Glipizide

Active substance: glipizide

TABLET · GLIPIZIDE 5 mg/1

United StatesActive

Marketing holder: Cardinal Health 107, LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Глибенез ретард
    таблетки с контролируемым высвобождением покрытые пленочной оболочкой, 10 мг (original in Russian, GRLS)
    П N014009/01
    Пфайзер ПГМ
  • Мовоглекен®
    таблетки, 5 мг (original in Russian, GRLS)
    ЛП-001191
    Жухай Юнайтед Лабораториз Ко.Лтд
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c5-0479-73aa-81bf-b21879ed3818;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2d2f-7701-85fa-a8e3258b2d37,01a1208c-6808-7935-87da-5b37dac362ec,01a1208c-6a1f-7464-a4f6-f923df5ff255,01a1208c-6af0-708b-9e46-66f96cf34e90,01a1208c-7791-7b1d-b761-5c9dfbf9c777;count=134 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
55154-7987
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 55154-7987 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 55154-7987 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 55154-7987 · Verified 2026-10-09 · open in source